Artiva Biotherapeutics, Inc. — All Filings
146 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
RW
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-24-182231 | Jul 22, 2024 | — |
| 4 | — | 0000905148-24-001964 | Jul 22, 2024 | — |
| 424B4 | 424B4 | 0001193125-24-181773 | Jul 22, 2024 | — |
| SEC STAFF LETTER | — | 9999999997-24-003294 | Jul 19, 2024 | — |
| 3 | — | 0001415889-24-019789 | Jul 18, 2024 | — |
| EFFECT | — | 9999999995-24-002197 | Jul 18, 2024 | — |
| 3 | — | 0000905148-24-001922 | Jul 18, 2024 | — |
| 3 | — | 0001415889-24-019804 | Jul 18, 2024 | — |
| 3 | — | 0001415889-24-019802 | Jul 18, 2024 | — |
| 3 | — | 0001415889-24-019801 | Jul 18, 2024 | — |
| 3 | — | 0001415889-24-019800 | Jul 18, 2024 | — |
| 3 | — | 0001415889-24-019798 | Jul 18, 2024 | — |
| 3 | — | 0001415889-24-019797 | Jul 18, 2024 | — |
| 3 | — | 0001415889-24-019796 | Jul 18, 2024 | — |
| 3 | — | 0001415889-24-019795 | Jul 18, 2024 | — |
| 3 | — | 0001415889-24-019794 | Jul 18, 2024 | — |
| 3 | — | 0001415889-24-019793 | Jul 18, 2024 | — |
| 3 | — | 0001415889-24-019792 | Jul 18, 2024 | — |
| 3 | — | 0001415889-24-019791 | Jul 18, 2024 | — |
| 3 | — | 0001415889-24-019790 | Jul 18, 2024 | — |
| 3 | — | 0001415889-24-019788 | Jul 18, 2024 | — |
| 3 | — | 0001415889-24-019787 | Jul 18, 2024 | — |
| S-1MEF | S-1MEF | 0001193125-24-181116 | Jul 18, 2024 | — |
| CERT | — | 0001354457-24-000493 | Jul 18, 2024 | — |
| CORRESP | — | 0001193125-24-179664 | Jul 16, 2024 | — |
| 8-A12B | 8-A12B | 0001193125-24-179648 | Jul 16, 2024 | — |
| CORRESP | — | 0001193125-24-179660 | Jul 16, 2024 | — |
| S-1/A | S-1/A | 0001193125-24-178806 | Jul 15, 2024 | — |
| CORRESP | — | 0001193125-24-175667 | Jul 5, 2024 | — |
| CORRESP | — | 0001193125-24-172249 | Jun 28, 2024 | — |
| S-1 | S-1 | 0001193125-24-172230 | Jun 28, 2024 | — |
| UPLOAD | — | 0000000000-24-007068 | Jun 21, 2024 | — |
| DRS/A | — | 0000950123-24-006157 | Jun 10, 2024 | — |
| DRSLTR | — | 0000950123-24-006158 | Jun 7, 2024 | — |
| SEC STAFF LETTER | — | 9999999997-24-002771 | May 31, 2024 | — |
| UPLOAD | — | 0000000000-24-006248 | May 30, 2024 | — |
| DRS | — | 0000950123-24-003803 | May 3, 2024 | — |
| RW | RW | 0001193125-22-275086 | Nov 1, 2022 | — |
| S-1/A | S-1/A | 0001193125-22-168492 | Jun 6, 2022 | — |
| S-1/A | S-1/A | 0001193125-22-068001 | Mar 7, 2022 | — |
| S-1/A | S-1/A | 0001193125-22-014926 | Jan 21, 2022 | — |
| S-1/A | S-1/A | 0001193125-21-358277 | Dec 16, 2021 | — |
| S-1 | S-1 | 0001193125-21-110347 | Apr 8, 2021 | — |
| D | — | 0001817241-21-000001 | Apr 5, 2021 | — |
| DRS | — | 0000950123-21-003225 | Mar 2, 2021 | — |
| D | — | 0001817241-20-000001 | Jul 10, 2020 | — |